MedTrace Logo

Effects of an Oral Nicotine Product in Smokeless Tobacco Users

NCT05280769 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 31

Last updated 2024-10-02

No results posted yet for this study

Summary

The purpose of this research study is to find out how three different nicotine pouches and participant's own brand of smokeless tobacco affect blood nicotine levels and how participants feel.

Conditions

  • Tobacco Use

Interventions

OTHER

oral nicotine pouch - 2 mg

"On" brand oral nicotine pouch with 2 mg of protonated nicotine in "original" flavor

OTHER

oral nicotine pouch - 4 mg

"On" brand oral nicotine pouch with 4 mg of protonated nicotine in "original" flavor

OTHER

oral nicotine pouch - 8 mg

"On" brand oral nicotine pouch with 8 mg of protonated nicotine in "original" flavor

OTHER

Smokeless tobacco

Participant's typical brand of smokeless tobacco

Sponsors & Collaborators

  • National Institute on Drug Abuse (NIDA)

    collaborator NIH

  • Virginia Commonwealth University

    lead OTHER

Principal Investigators

  • Alison Breland, PhD · Virginia Commonwealth University

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-08-23
Primary Completion
2023-11-28
Completion
2023-11-28

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05280769 on ClinicalTrials.gov